CDKN2A and astrocytoma (excluding glioblastoma): In our cohort, 3 out of 20 IDH-mutant astrocytomas and none out of 8 IDH-mutant oligodendrogliomas contained CDKN2A HD, overall consistent with prior reported frequencies [9] (Additional file 1: Data 2).